Skip to content
Search

Latest Stories

Blood tests for Alzheimer's diagnosis could be available on NHS within five years

These tests can diagnose Alzheimer’s disease earlier and more accurately than current methods 

 A £5m project has been launched to introduce new blood tests in the National Health Service (NHS) that can diagnose Alzheimer’s disease.


The blood tests could be available on the NHS within five years and they can diagnose the disease earlier and more accurately than current methods, experts have said.

Alzheimer’s Research UK, the Alzheimer’s Society and the National Institute of Health and Care Research have jointly launched the project.

Susan Kohlhaas, Executive Director of Research and Partnerships at Alzheimer’s Research UK, said that the NHS doesn’t possess the “required levels of diagnostic infrastructure” to cope with the “growing demand” for dementia diagnosis.

“Low-cost tools like blood tests that are non-invasive and simpler to administer than current gold standard methods are the answer to this,” she added.

Fiona Carragher, Director of Research and Influencing at the Alzheimer’s Society, said implementing a blood test for dementia into UK healthcare systems would be “a truly game-changing win in the fight against this devastating disease.”

Diagnosis of Alzheimer’s to become easier

According to Kohlhaas, diagnosis of Alzheimer’s is currently done through brain imaging or lumbar punctures that can be “invasive and come with uncomfortable side effects.”

Lumbar puncture is a process of diagnosis in which a sample of spinal fluid is drawn from the lower back.

The 2023 Dementia Attitudes Monitor survey also revealed that blood tests for diagnosing dementia would be much more acceptable to the public than the existing tests.

More than half of UK adults would be reluctant to undergo a lumbar puncture, but over 90 per cent of respondents would be willing to take a blood test, the survey found.

Several blood tests for Alzheimer’s are currently in the research stages. Some of these look for specific proteins, such as amyloid and tau, that occur before dementia symptoms appear.

However, so far, no test has been clinically validated in the UK, or made available to patients in the NHS.

Funds for the new project have been raised by players of People’s Postcode Lottery, and it will involve working with world-class researchers, Alzheimer’s Research UK stated.

More For You

Hay fever treatment: Dymista nasal spray now available in pharmacies without prescription

Hay fever affects one in four people in the UK

gettyimages

Hay fever treatment: First OTC combination nasal spray launched

For the first time, a double-action combination treatment for moderate to severe hay fever has been available over the counter across UK pharmacies, offering a new option for those sufferers who remain uncontrolled on a corticosteroid or antihistamine nasal spray.

Launched by global healthcare company Viatris, Dymista® CONTROL (azelastine hydrochloride and fluticasone propionate) nasal spray— previously only available via prescription under the brand name Dymista — can be accessed without a GP visit.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less